Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts RemSense Capital Raising August 4, 2025 Tech 5: Tesla and Samsung Strike Deal, Palo Alto to Acquire CyberArk August 3, 2025 Albemarle Swings to Profit, Lowers Spending Amid Prolonged Lithium Slump August 2, 2025